Oct. 15 at 4:52 PM
New Episode: WTR Healthcare Happenings with Amit Kumar CEO of Anixa Biosciences (NASDAQ:
$ANIX)
🔹 Discusses t-cell innovation and two groundbreaking clinical programs:
🔹 Modified CAR-T therapy designed to overcome challenges in treating solid tumors, including ovarian cancer
🔹 A breast cancer vaccine training antigen-specific t-cells to target triple-negative breast cancer — the most aggressive form
🔹 Hear insights on Anixa’s financial strength and strategy to drive these programs toward commercialization
🎧 Listen now on Apple Podcasts, Spotify, or at our website!
Apple: https://podcasts.apple.com/us/podcast/ceo-dr-amit-kumar-discusses-anixa-biosciences-innovative/id1795488592?i=1000731955891
Spotify: https://open.spotify.com/episode/2hEd8syJqnZzNBMfh9vdWs?si=c3cdaf92c2374d67
Website: https://www.watertowerresearch.com/media-detail/2652/Media
Others: https://pod.link/1795488592
#AnixaBiosciences
$ANIX #Biotech #CancerResearch #CAR_T #Immunotherapy #BreastCancer #OvarianCancer #HealthcareInvesting #SmallCapStocks #WaterTowerResearch